ScholarLens Back to search
2003•Chinese Journal of Clinical HepatologyRequires access

Clinical study on the treatment of hepatic cancer with RFA combined with percaulaneous ethanol injection

Cui Zhong

Open publisher page 0 citations

Abstract

To evaluate the clinical effect of RFA combined with percaulaneous ethanol injection. 81 cases of hepatic cancer which was not suitable for operation was divided into two groups. 41 cases were treated with RFA combined with percaulaneous ethanol injection and 40 cases with RFA only. In RFA combined with percaulaneous ethanol injection group. cancer shrinked in 29 cases.AFP decreased in 20 primary cancer cases whose AFP was positive. In RFA group, the hepatic cancer shrinked in 19 cases. AFP in 18/24 primary cancer cases decreased. There was no severe. complications in two groups. The difference of AFP decreasing ratio was significant in two groups (P0.05) The difference of shrinking ratio was significant in two groups (P0.05). The treatment of RFA combined with percaulaneous ethanol injection was a safe and effective therapy for hepatic cancer, and may elevate the treatment effect of hepatic cancer.

About this research paper

What this paper is about

To evaluate the clinical effect of RFA combined with percaulaneous ethanol injection. 81 cases of hepatic cancer which was not suitable for operation was divided into two groups. 41 cases were treated with RFA combined with percaulaneous ethanol injection and 40 cases with RFA only. In RFA combined with percaulaneous ethanol injection group. cancer shrinked in 29 cases.AFP decreased in 20 primary cancer cases whose AFP was positive. In RFA group, the hepatic cancer shrinked in 19 cases. AFP in 18/24 primary cancer cases decreased. There was no severe. complications in two groups. The difference of AFP decreasing ratio was significant in two groups (P0.05) The difference of shrinking ratio was significant in two groups (P0.05). The treatment of RFA combined with percaulaneous ethanol injection was a safe and effective therapy for hepatic cancer, and may elevate the treatment effect of hepatic cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To evaluate the clinical effect of RFA combined with percaulaneous ethanol injection. 81 cases of hepatic cancer which was not suitable for operation was divided into two groups. 41 cases were treated with RFA combined with percaulaneous ethanol injection and 40 cases with RFA only. In RFA combined with percaulaneous ethanol injection group. cancer shrinked in 29 cases.AFP decreased in 20 primary cancer cases whose AFP was positive. In RFA group, the hepatic cancer shrinked in 19 cases. AFP in 18/24 primary cancer cases decreased. There was no severe. complications in two groups. The difference of AFP decreasing ratio was significant in two groups (P0.05) The difference of shrinking ratio was significant in two groups (P0.05). The treatment of RFA combined with percaulaneous ethanol injection was a safe and effective therapy for hepatic cancer, and may elevate the treatment effect of hepatic cancer.

Key concepts: Medicine, Cancer, Significant difference, Gastroenterology, Ethanol, Liver cancer, Internal medicine, Therapeutic effect

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical study on the treatment of hepatic cancer with RFA combined with percaulaneous ethanol injection — Research Paper | ScholarLens